OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 829, doi. 10.1096/fba.2021-00039
- By:
- Publication type:
- Article
Works matching IS 25739832 AND DT 2021 AND VI 3 AND IP 10
Results: 9
1
2
Nerve density in cancer: Less is better.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 773, doi. 10.1096/fba.2021-00046
- By:
- Publication type:
- Article
3
Sheep models of F508del and G542X cystic fibrosis mutations show cellular responses to human therapeutics.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 841, doi. 10.1096/fba.2021-00043
- By:
- Publication type:
- Article
4
The role of peripheral nerve signaling in endometriosis.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 802, doi. 10.1096/fba.2021-00063
- By:
- Publication type:
- Article
5
ROCK inhibitors modulate the physical properties and adipogenesis of 3D spheroids of human orbital fibroblasts in different manners.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 866, doi. 10.1096/fba.2021-00037
- By:
- Publication type:
- Article
6
Adaptive responses to air pollution in human dermal fibroblasts and their potential roles in aging.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 855, doi. 10.1096/fba.2021-00056
- By:
- Publication type:
- Article
7
Life with FASEB for three decades.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 814, doi. 10.1096/fba.2021-00068
- Publication type:
- Article
8
Friends and foes: Extracellular vesicles in aging and rejuvenation.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 787, doi. 10.1096/fba.2021-00077
- By:
- Publication type:
- Article
9
Issue Information.
- Published in:
- FASEB Bioadvances, 2021, v. 3, n. 10, p. 769, doi. 10.1096/fba.1140
- Publication type:
- Article